Barbara-Jean Anne Bormann-Kennedy, Director of Xeris Biopharma Holdings XERS, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $203.8K. The latest trade was on 06/04.

BB

BB

Barbara-Jean Anne Bormann-Kennedy

Director

Company

Xeris Biopharma Holdings XERS

First filing

23/06/07

Trades

7 trades

Buys / sales

0 / 2

12-month net buying

−$203.8K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	06/04	06/05	16,000 sh	$6.09	$97,440	−11.2%
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	25/12/12	25/12/15	15,000 sh	$7.09	$106,350	−9.5%